Peter CarmelietMD, PhD
Dr. Peter Carmeliet is Director of the VIB - Vesalius Research Center, at the University of Leuven in Belgium. He graduated as Doctor in Medicine in 1984, and completed his PhD in Medicine in 1989.
After his return to Leuven in 1992, Dr. Carmeliet started his own research group with a focus on how blood vessels grow (angiogenesis) in health and disease. By developing transgenic mice lacking VEGF, he discovered that VEGF is a key player in angiogenesis.
Dr. Carmeliet's findings have led to the (pre) clinical development of novel therapeutic strategies for angiogenic diseases. He also showed that PlGF is a diseaserestricted candidate in many angiogenic disorders and tested the therapeutic potential of anti-PlGF.